课题基金 / 基金详情

Prediction, verification, and clinical significance of splicing aberrations associated with BRCA1 and BRCA2 variants

Prediction, verification, and clinical significance of splicing aberrations associated with BRCA1 and BRCA2 variants
与 BRCA1 和 BRCA2 变异相关的剪接畸变的预测、验证和临床意义
批准号:
nhmrc : 1010719
负责人:
Dr Sean Tavtigian
金额:
$38.21万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2011
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2011-01-01 至 2013-12-31

项目摘要

项目成果

Dr Sean Tavtigian的其他基金

相似基金

相关文献

中文摘要
翻译
有许多家族的乳腺癌基因BRCA1和BRCA2序列发生变化,其后果难以预测。不可能向这些妇女或其面临风险的家庭成员提供信息丰富的遗传咨询。这项研究旨在完善计算机预测模型,用于预测序列变化是否会破坏基因产物在细胞中的排列方式,以及破坏的程度将导致癌症。这将改善患者管理。
英文摘要
There are many families with sequence changes in the breast cancer genes BRCA1 and BRCA2 for which the consequences cannot be easily predicted. It is not possible to offer informative genetic counselling to these women or their at-risk family members. This study aims to refine computer prediction models that are used to predict if sequence changes disrupt the way the gene product is collated in the cell, and what amount of disruption will lead to cancer. This will improve patient management.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identification of new mutations that contribute to breast cancer
  • 批准号:
    nhmrc : 401651
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $21.59万
  • 财政年份:
    2007
  • 负责人:
    Dr Sean Tavtigian
  • 依托单位:
海外基金